Pharvaris N.V. - PHVS

Sector: Healthcare · Industry: Pharmaceutical Preparations

Website: No information yet · Social: No information yet

Company profile

Latest / Compare

Q1 2026 · Q4 2025

Value (USD)

Total reported value ($000)

$1.67B

QoQ value delta ($000)

+$29.84M (+1.82%)

Implied price effect (QoQ)

+1.81%

Total shares

59,117,322

QoQ shares delta

+4,410 (+0.01%)

Total shares held by funds (by quarter)

Interactive chart by TradingView.

Top 25 only Full list

Partial Q1 2026 data: 111 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.

Manager	Value ($000)	Shares	% of 13F
GENERAL ATLANTIC, L.P.	226,882	8,031,252	10.56%
FMR LLC	177,536	6,284,472	0.01%
Foresite Capital Management IV, LLC	134,994	4,778,581	56.94%
venBio Partners LLC	131,060	4,639,304	46.71%
VIKING GLOBAL INVESTORS LP	103,206	3,653,310	0.29%
EQT Fund Management S.a r.l.	96,745	3,424,609	9.48%
DEERFIELD MANAGEMENT COMPANY, L.P.	88,310	3,126,042	1.04%
Bain Capital Life Sciences Investors, LLC	75,583	2,675,509	6.82%
WELLINGTON MANAGEMENT GROUP LLP	59,858	2,118,900	0.01%
Commodore Capital LP	54,210	1,918,970	3.14%
Novo Holdings A/S	49,437	1,750,000	4.01%
Saturn V Capital Management LP	33,939	1,201,402	6.15%
Point72 Asset Management, L.P.	28,448	1,007,016	0.04%
Cormorant Asset Management, LP	28,250	1,000,000	1.42%
Sofinnova Investments, Inc.	23,117	818,328	0.88%
5AM Venture Management, LLC	22,532	797,600	6.26%
Polar Capital Holdings Plc	22,063	781,016	0.08%
BlackRock, Inc.	21,391	757,213	0.0%
Soleus Capital Management, L.P.	19,832	702,052	0.8%
Rock Springs Capital Management LP	18,236	645,533	1.07%
Kynam Capital Management, LP	18,091	640,395	1.12%
Patient Square Capital LP	13,927	493,000	2.47%
Ikarian Capital, LLC	13,753	486,856	1.12%
Elmind Capital, LP	13,439	475,750	3.82%
BALYASNY ASSET MANAGEMENT L.P.	13,058	462,251	0.02%